Basit öğe kaydını göster

dc.contributor.authorGüler N.
dc.contributor.authorDağda? S.
dc.contributor.authorGül Ö.
dc.contributor.authorTopgül K.
dc.contributor.authorMalazgirt Z.
dc.contributor.authorGürgenyataği D.
dc.date.accessioned2020-06-21T09:23:31Z
dc.date.available2020-06-21T09:23:31Z
dc.date.issued2005
dc.identifier.issn1108-2682
dc.identifier.urihttps://hdl.handle.net/20.500.12712/3584
dc.description.abstractSince incidence of gestational thrombocytopenia is 5% during pregnancy, gestational immune thrombocytopenic purpura (ITP) should be differentiated from gestational thrombocytopenia. In gestational ITP, corticosteroids, intravenous immunoglobulin (IVIG) therapy and splenectomy are reliable treatment options. We present a patient diagnosed as ITP on 13th gestational week given IVIG who refused to take IVIG during the course of therapy and interrupted treatment. During her treatment, she was convinced to receive IVIG for a period but then refused again to take this treatment later. Her treatment was continued with steroids. Laparosopic splenectomy was performed at postpartum period. Copyright © Hellenic Society of Haematology.en_US
dc.language.isoengen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectITPen_US
dc.subjectPregnancyen_US
dc.subjectSplenectomyen_US
dc.titleA pregnant patient with ITP and an acquired Bernard Soulier syndrome who interfered with treatment planen_US
dc.typearticleen_US
dc.contributor.departmentOMÜen_US
dc.identifier.volume8en_US
dc.identifier.issue4en_US
dc.identifier.startpage686en_US
dc.identifier.endpage689en_US
dc.relation.journalHAEMAen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster